Related Experiment Video
Updated: Jul 24, 2025

05:58
Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
Published on: October 13, 2023
1.3K
Microfluidics-Enabled Isolation and Single-Cell Analysis of Circulating Tumor Cells
Minh-Chau N Le1, Kierstin A Smith1, Morteza Alipanah1
1Interdisciplinary Microsystems Group, Department of Mechanical and Aerospace Engineering, University of Florida, Gainesville, FL, USA.
Methods in Molecular Biology (Clifton, N.J.)
|July 10, 2023
Summary
Microfluidic devices can isolate and analyze circulating tumor cells (CTCs) from blood. This technology aids in cancer diagnosis, prognosis, and developing new cancer drugs by studying tumor characteristics.
Area of Science:
- Oncology
- Biotechnology
- Medical Diagnostics
Background:
- Circulating tumor cells (CTCs) are crucial biomarkers for cancer management.
- Microfluidic platforms offer advanced tools for CTC isolation and analysis.
- Understanding CTCs aids in cancer diagnosis, prognosis, and personalized treatment strategies.
Purpose of the Study:
- To present protocols for fabricating and utilizing a microfluidic device for CTC analysis.
- To demonstrate the application of microfluidics in enriching and detecting single CTCs.
- To highlight the role of CTC analysis in cancer drug development and theranostics.
Main Methods:
- Fabrication of a specialized microfluidic device.
- Isolation and enrichment of CTCs from patient blood samples.
- Detection and analysis of single CTCs using immunocytochemistry/immunofluorescence (ICC/IF) assays.
Main Results:
- Successful enrichment and detection of single CTCs from sarcoma patient blood.
- Demonstration of microfluidic platform's capability for CTC analysis.
- Data generated can inform cancer diagnosis, prognosis, and treatment response prediction.
Conclusions:
- Microfluidics combined with ICC/IF assays provide a powerful method for CTC analysis.
- This approach facilitates the study of tumor heterogeneity and aids cancer drug development.
- The developed microfluidic device offers a valuable tool for clinical applications in oncology.

